Covered recipient · General Payments record
GRANT BULLOCK
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2024
$1,340.13
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $885.52 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $397.49 | 4 |
| Neurocrine BioSciences, Inc. | $174.92 | 1 |
| Otsuka America Pharmaceutical, Inc. | $157.32 | 3 |
| Vanda Pharmaceuticals Inc. | $117.33 | 1 |
| Almatica Pharma Inc. | $23.02 | 1 |
| Lundbeck LLC | $15.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.87 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103389431 | CMS |
| ABBVIE INC. | $124.37 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103389433 | CMS |
| ABBVIE INC. | $125.00 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103389435 | CMS |
| ABBVIE INC. | $120.25 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103389437 | CMS |
| Almatica Pharma LLC | $23.02 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137558705 | CMS |
| Lundbeck LLC | $15.44 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145901340 | CMS |
| Neurocrine Biosciences, Inc. | $174.92 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150806078 | CMS |
| Otsuka America Pharmaceutical, Inc. | $120.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118868936 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.33 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118868938 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.93 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118868940 | CMS |
| Vanda Pharmaceuticals Inc. | $117.33 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133898349 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.